Tadashi Kimura

mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary

Seiji Mabuchi, Chiaki Kawase, Deborah A. Altomare et al. · Clinical Cancer Research · 2009 · 155 citations · Full text

Medicine, Oncology, Pharmacology +17

The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer

Mahiru Kawano, Seiji Mabuchi, Yuri Matsumoto et al. · Scientific Reports · 2015 · 147 citations · Full text

Medicine, Immunology, Oncology +15

Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma

Eriko Yokoi, Seiji Mabuchi, Ryoko Takahashi et al. · Journal of Gynecologic Oncology · 2016 · 118 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Impact of histological subtype on survival of patients with surgically-treated stage IA2–IIB cervical cancer: Adenocarcinoma versus squamous cell carcinoma

Seiji Mabuchi, Mika Okazawa, Koji Matsuo et al. · Gynecologic Oncology · 2012 · 115 citations

Medicine, Oncology, Surgery +14

Whole-genome sequencing revealed novel prognostic biomarkers and promising targets for therapy of ovarian clear cell carcinoma

Hiroaki Itamochi, Tetsuro Oishi, Nao Oumi et al. · British Journal of Cancer · 2017 · 110 citations · Full text

Medicine, Molecular Genetics, Oncology +17